The Journal of Urology
Volume 182, Issue 2 , Pages 728-734, August 2009

CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma Prognosis

  • Michela de Martino

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • Equal study contribution.
    • ,
  • Tobias Klatte

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • Equal study contribution.
    • ,
  • David B. Seligson

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of California-Los Angeles, Los Angeles, California
    • ,
  • Jeffrey LaRochelle

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • ,
  • Brian Shuch

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • ,
  • Randy Caliliw

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • ,
  • Zhenhua Li

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • ,
  • Fairooz F. Kabbinavar

      Affiliations

    • Department of Medicine, University of California-Los Angeles, Los Angeles, California
    • ,
  • Allan J. Pantuck

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • Financial interest and/or other relationship with POM Wonderful, Novartis, Pfizer and Wilex.
    • ,
  • Arie S. Belldegrun

      Affiliations

    • Department of Urology, University of California-Los Angeles, Los Angeles, California
    • Corresponding Author InformationCorrespondence: Division of Urologic Oncology, Department of Urology, University of California-Los Angeles, 650 Charles East Young Dr., Los Angeles, California 90095-1738 (telephone: 310-206-1434; FAX: 310-206-5343)

Received 28 October 2008 published online 18 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

 See Editorial on page 425.

PII: S0022-5347(09)00878-7

doi:10.1016/j.juro.2009.03.077

Refers to article:

  • Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma , 15 June 2009

    Thomas A. Gardner, Theodore Logan
    The Journal of Urology August 2009 (Vol. 182, Issue 2, Pages 425-426)

The Journal of Urology
Volume 182, Issue 2 , Pages 728-734, August 2009

Article Tools

* Image Usage & Resolution